Large research symposium highlights liquid biopsies, new drug combos, shifts in surgical practice and, yes, patient voices.

Future Oncol. 2008;4(4):501-503. Thus, the major role of PET scanning seems to be detection of distant metastasis, local recurrence and monitoring response to treatment. This technique allows ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The exciting findings that we're presenting in the poster ...

It felt suffocating at first. I was suddenly in a hospital bed, with metastatic cancer up and down my bones, across both lungs, in my brain. I desperately wanted to find other cancer patients who ...

Metastatic spine cancer, a condition where cancer cells spread from different regions to the spinal cord or vertebrae, affects a significant portion of cancer patients. We spoke to our expert Dr ...

BRAFTOVI in combination with cetuximab and mFOLFOX6 is the first and only combination regimen with targeted therapy approved for use as early as first-line for patients with metastatic colorectal ...

Relevance section written by JCO Clinical Cancer Informatics Associate Editor Ziad Bakouny, MD, MSc. The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) prognostic model was ...

FDA approved Braftovi, Erbitux, and mFOLFOX6 for BRAF V600E mutation-positive metastatic colorectal cancer. BREAKWATER trial showed a 61% objective response rate for the treatment group versus 40% for ...

The diagnostic workup included MRI and PET/CT, which highlighted the tumor’s aggressive nature and metastatic potential. Subsequent metastases to the pleura, lymph nodes, and, less frequently, to the ...

After treating metastatic ovarian cancer models with both β-glucan and IFNγ, total tumor burden “shrank substantially”, relative to controls. The disease reversal was consistent even in ...